[144] Delta Air Lines, Inc. SEC Filing
Rhea-AI Filing Summary
Delta Air Lines insider notice reports a proposed sale of 2,500 common shares through Fidelity Brokerage Services with an approximate sale date of 08/19/2025. The filing lists the aggregate market value of the shares as $151,763.25 and indicates 652,948,402 shares outstanding for the issuer. The securities being sold were acquired as restricted stock vesting: 2,320 shares vested on 06/20/2019 and 180 shares vested on 06/15/2024, both recorded as compensation. The filer reports no sales in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for a small insider sale; appears procedural and not materially market-moving.
This Form 144 records a proposed sale of 2,500 common shares valued at $151,763.25 against a large outstanding base of 652,948,402 shares, indicating the transaction represents a negligible percentage of the company’s float. The shares originated from restricted stock vesting events in 2019 and 2024 and were compensated, which is common for employee holders. The filer reports no sales in the prior three months and provides the standard certifying language regarding material nonpublic information. Based solely on the filing’s facts, there is no evidence of material corporate events or forced liquidation.
TL;DR: Compliance-focused disclosure showing a planned insider sale under Rule 144; governance procedures appear followed.
The notice names Fidelity Brokerage Services as the executing broker and documents acquisition dates and payment nature (compensation) for the vested restricted stock, which supports transparency around insider liquidity. The absence of reported sales in the preceding three months suggests this is an isolated transaction rather than part of a larger, potentially signaling pattern. The filing includes the required attestation about knowledge of material adverse information, consistent with regulatory expectations for insider dispositions.